ISIvana Stefanović

Ivana Stefanović

*This is an algorithmically generated author record based on publicly available information.

Ivana Stefanović has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Self-Rated Health and Burnout Dimensions Among Prehospital Emergency Medical Services Physicians: A Cross-Sectional Study

    by Veroslava V. Stanković, Dragana P. Jović, Nataša K. Rančić, Ivana D. Milivojčević Bevc, Goran Z. Čolaković, Ivana M. Stefanović, Danijela M. Tasić-Uroš

    This study examined associations between self-rated health (SRH) and burnout dimensions among prehospital emergency physicians. This cross-sectional study included a convenience sample of 151 physicians from one emergency medical service in Belgrade, Serbia. Burnout was assessed using the Maslach Burnout Inventory–Human Services Survey and SRH using a single SF-36 general-health item. Ordinal models examined three ordered SRH categories (excellent/very good, good, and fair/poor), with burnout dimensions entered separately and jointly, adjusting for age, sex, professional qualification, and chronic disease. Binary sensitivity analyses compared fair/poor with excellent/very good/good health. Higher emotional exhaustion was associated with less favourable SRH in the separate adjusted ordinal model (OR per 10-point increase: 1.31; 95% CI 1.04–1.64). After mutual adjustment for burnout dimensions, the estimate remained similar but was less precise (OR 1.30; 95% CI 0.96–1.75). Evidence was also inconclusive in the adjusted binary analysis. Depersonalisation and reduced personal accomplishment showed no clear adjusted associations with SRH. Unadjusted associations of shift work and daily working hours with SRH were inconclusive. Emotional exhaustion may be associated with physicians’ perceived health, although the evidence varied across models. The cross-sectional design precludes conclusions about direction or causality; longitudinal studies are needed.

  • Open Access

    When myocardial infarction is not just inferior: The importance of recognising right ventricular infarction in the prehospital setting

    by Andrijana Ilić, Verica Vukićević, Vanja Zmijarević, Olja Mirković, Ivana Stefanović, Radmila Ristić-Mrkalj, Bojana Aćimović

    Introduction: Right ventricular myocardial infarction (RVMI) occurs as a consequence of an acute right coronary artery occlusion proximal to the branches supplying the right ventricular free wall. It rarely occurs as an isolated entity but presents as a complication of approximately 50% inferior myocardial infarctions. It is clinically characterised by the triad of arterial hypotension, elevated jugular venous pressure, and an absence of pulmonary congestion. In this setting, vasodilator therapy is contraindicated, while prompt intravenous volume loading represents the cornerstone of initial management. Case Presentation: A 50-year-old male presented with an acute onset of bilateral shoulder pain, nausea, and diaphoresis. The initial 12-lead electrocardiogram demonstrated an inferior STEMI, with maximal ST-segment elevation in lead III, suggestive of right coronary artery involvement. In the presence of hypotension, jugular venous distension, and clear lung fields, right-sided precordial leads were obtained, revealing ST-segment elevation in leads V4R-V6R, consistent with right ventricular involvement (Erhardt's sign). A rapid intravenous bolus of 0.9% sodium chloride was administered, resulting in hemodynamic stabilisation. The patient was urgently transferred to the cardiac catheterisation laboratory under continuous electrocardiographic and hemodynamic monitoring for primary percutaneous coronary intervention. Conclusion: Right ventricular myocardial infarction is associated with an unfavourable prognosis and carries a significant risk of iatrogenic complications if not promptly recognised. Early identification of RVMI and timely initiation of appropriate therapy are essential, especially in the prehospital setting.

  • Open Access

    Short bowel syndrome and intestinal failure in adults: Anatomy-driven phenotypes, adaptation biology, and contemporary intestinal rehabilitation

    by Ivana Milivojević-Bevc, Milica Dimitrijević-Stojanović, Bojana Stojanović, Goran Čolaković, Ivana Stefanović, Danijela Tasić-Uroš

    Short bowel syndrome (SBS) is the leading cause of chronic intestinal failure in adults and most commonly follows extensive small-bowel resection. The resulting loss of absorptive surface and regulatory feedback leads to a spectrum of malabsorption syndromes, ranging from compensated intestinal insufficiency to intestinal failure requiring long-term parenteral support. Clinical outcomes are determined more by postoperative anatomy than by residual length alone, particularly the presence of colon continuity and the preservation of the distal ileum and the ileocecal region. The pathophysiology of SBS integrates reduced absorptive capacity, accelerated transit, gastric hypersecretion, disordered bile acid handling, microbiome perturbation, and impaired enteroendocrine signalling. Intestinal adaptation, driven by luminal nutrients and trophic hormones such as GLP-2, can partially restore function over months to years, enabling stepwise reduction of parenteral support in selected patients. Modern care is centred on structured intestinal rehabilitation delivered by multidisciplinary teams, combining individualised fluid-electrolyte strategy, optimised oral/enteral nutrition, targeted pharmacotherapy to control secretion and motility, prevention and management of catheter-related complications, and selective reconstructive surgery. Disease-modifying therapy with GLP-2 analogues can reduce parenteral support requirements in SBS-associated intestinal failure, while transplantation remains reserved for refractory, life-threatening complications. This review summarises current concepts and evidence-based principles for diagnosis, phenotype stratification, rehabilitation, and long-term surveillance in adult SBS.

  • Open Access

    Epidermolysis bullosa

    by Slađana Anđelić, Ivana Stefanović, Danijela Tasić-Uroš, Bevc Milivojčević, Nikola Savić

    Epidermolysis bullosa (EB) is a hereditary multisystemic disease caused by genetic defects in the skin's structural proteins. Depending on the type of disease, symptoms vary from localised fragility and bullae to a widespread generalised form, including extracutaneous manifestations. In the most severe forms, EB causes death in the earliest period of life. The treatment of EB is complex and usually requires the involvement of several different specialists. Without curative therapy, treatment is oriented towards supportive care, symptom control, and preventing mild to severe complications. Vector gene therapy Vyjuvek (beremagene geperpavec), based on the herpes simplex virus type 1, is a new hope for treating wounds in patients older than six months who suffer from dystrophic forms of EB.